• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ga-PSMA PET/CT 在高危前列腺癌原发淋巴结分期中的准确性。

The accuracy of Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer.

机构信息

Department of Urology, Acibadem Taksim Hospital, Inonu Mah., Nizamiye Cad. No:1, 34373 Sisli, Istanbul, Turkey.

Department of Nuclear Medicine, Sisli Etfal Training and Research Hospital, Istanbul, Turkey.

出版信息

Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1806-1812. doi: 10.1007/s00259-017-3752-y. Epub 2017 Jun 18.

DOI:10.1007/s00259-017-3752-y
PMID:28624849
Abstract

PURPOSE

To assess the diagnostic accuracy of Ga-PSMA PET in predicting lymph node (LN) metastases in primary N staging in high-risk and very high-risk nonmetastatic prostate cancer in comparison with morphological imaging.

METHODS

This was a multicentre trial of the Society of Urologic Oncology in Turkey in conjunction with the Nuclear Medicine Department of Cerrahpasa School of Medicine, Istanbul University. Patients were accrued from eight centres. Patients with high-risk and very high-risk disease scheduled to undergo surgical treatment with extended LN dissection between July 2014 and October 2015 were included. Either MRI or CT was used for morphological imaging. PSMA PET/CT was performed and evaluated at a single centre. Sensitivity, specificity and accuracy were calculated for the detection of lymphatic metastases by PSMA PET/CT and morphological imaging. Kappa values were calculated to evaluate the correlation between the numbers of LN metastases detected by PSMA PET/CT and by histopathology.

RESULTS

Data on 51 eligible patients are presented. The sensitivity, specificity and accuracy of PSMA PET in detecting LN metastases in the primary setting were 53%, 86% and 76%, and increased to 67%, 88% and 81% in the subgroup with of patients with ≥15 LN removed. Kappa values for the correlation between imaging and pathology were 0.41 for PSMA PET and 0.18 for morphological imaging.

CONCLUSIONS

PSMA PET/CT is superior to morphological imaging for the detection of metastatic LNs in patients with primary prostate cancer. Surgical dissection remains the gold standard for precise lymphatic staging.

摘要

目的

与形态影像学相比,评估 Ga-PSMA PET 在预测高危和极高危非转移性前列腺癌原发 N 分期中淋巴结(LN)转移的诊断准确性。

方法

这是土耳其泌尿肿瘤学会与伊斯坦布尔大学 Cerrahpasa 医学院核医学系合作进行的一项多中心试验。从 8 个中心招募患者。纳入计划接受扩大 LN 解剖手术治疗的高危和极高危疾病患者。使用 MRI 或 CT 进行形态影像学检查。PSMA PET/CT 在一个中心进行并进行评估。计算 PSMA PET/CT 和形态影像学检测淋巴转移的敏感性、特异性和准确性。计算 Kappa 值以评估 PSMA PET/CT 和组织病理学检测到的 LN 转移数量之间的相关性。

结果

报告了 51 名符合条件患者的数据。PSMA PET 在原发性疾病中检测 LN 转移的敏感性、特异性和准确性分别为 53%、86%和 76%,在去除≥15 个 LN 的亚组中分别增加到 67%、88%和 81%。PSMA PET 与影像学之间的相关性的 Kappa 值为 0.41,形态影像学为 0.18。

结论

PSMA PET/CT 比形态影像学更能检测原发性前列腺癌患者的转移性 LN。手术解剖仍然是精确淋巴分期的金标准。

相似文献

1
The accuracy of Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer.Ga-PSMA PET/CT 在高危前列腺癌原发淋巴结分期中的准确性。
Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1806-1812. doi: 10.1007/s00259-017-3752-y. Epub 2017 Jun 18.
2
Prospective evaluation of the performance of [Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy.对[镓]镓-PSMA-11 PET/CT(MRI)在根治性前列腺切除术后接受超广泛挽救性淋巴结清扫术患者的淋巴结分期中的性能进行前瞻性评估。
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2169-2177. doi: 10.1007/s00259-019-04361-0. Epub 2019 Jun 29.
3
How accurate is Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(Ga-PSMA PET/CT)在中高危前列腺癌根治性前列腺切除术前对原发性淋巴结分期的准确性如何?一项基于患者和淋巴结的分析研究。
Urol Oncol. 2022 Jan;40(1):6.e1-6.e9. doi: 10.1016/j.urolonc.2021.07.006. Epub 2021 Aug 13.
4
Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.术前 3-T 多参数 MRI 和 Ga-PSMA PET/CT 扫描对前列腺癌根治性前列腺切除术和盆腔淋巴结清扫术病理结果的预测价值的组织学比较。
BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7.
5
Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.68Ga-PSMA HBED-CC PET 对生化复发前列腺癌患者淋巴结转移评估的价值:与挽救性淋巴结切除术后组织病理学的比较。
J Nucl Med. 2016 Nov;57(11):1713-1719. doi: 10.2967/jnumed.116.173492. Epub 2016 Jun 3.
6
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
7
Comparison of Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer.镓-PSMA-11 PET-CT 与 mpMRI 用于中高危前列腺癌患者术前淋巴结分期的比较。
J Transl Med. 2017 Nov 7;15(1):230. doi: 10.1186/s12967-017-1333-2.
8
Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate Cancer.基于前列腺癌肿瘤分化分层的Ga-PSMA PET/CT与PET阳性淋巴结的体积形态学
J Nucl Med. 2017 Dec;58(12):1949-1955. doi: 10.2967/jnumed.116.185033. Epub 2017 Jun 21.
9
Ga-PSMA PET/CT based primary staging and histological correlation after extended pelvic lymph node dissection at radical prostatectomy.基于镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(Ga-PSMA PET/CT)的根治性前列腺切除术中扩大盆腔淋巴结清扫术后的初始分期及组织学相关性研究
World J Urol. 2020 Dec;38(12):3085-3090. doi: 10.1007/s00345-020-03131-0. Epub 2020 Feb 26.
10
Potential Impact of Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.镓-PSMA-11 PET/CT 对前列腺癌根治性放疗计划的潜在影响。
J Nucl Med. 2018 Nov;59(11):1714-1721. doi: 10.2967/jnumed.118.209387. Epub 2018 Apr 13.

引用本文的文献

1
[Options in nuclear medicine for advanced prostate cancer in practice].[核医学在晚期前列腺癌实际治疗中的选择]
Urologie. 2025 Aug 18. doi: 10.1007/s00120-025-02659-6.
2
A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer.一项将PSMA-PET与FDG-PET用于新诊断的高危前列腺癌分期的前瞻性多中心试验。
EJNMMI Res. 2025 Jul 24;15(1):92. doi: 10.1186/s13550-025-01265-z.
3
Performance of F-DCFPyL PET/CT in Primary Prostate Cancer Diagnosis, Gleason Grading and D'Amico Classification: A Radiomics-Based Study.

本文引用的文献

1
Impact of PET acquisition durations on image quality and lesion detectability in whole-body Ga-PSMA PET-MRI.PET采集时长对全身镓-PSMA PET-MRI图像质量和病灶可检测性的影响
EJNMMI Res. 2017 Dec;7(1):12. doi: 10.1186/s13550-017-0261-8. Epub 2017 Feb 6.
2
18F-PSMA-1007 PET/CT Detects Micrometastases in a Patient With Biochemically Recurrent Prostate Cancer.18F-PSMA-1007 PET/CT检测生化复发前列腺癌患者的微转移灶
Clin Genitourin Cancer. 2017 Jun;15(3):e497-e499. doi: 10.1016/j.clgc.2016.12.029. Epub 2016 Dec 29.
3
Salvage Lymph Node Dissection for Node-only Recurrence of Prostate Cancer: Ready for Prime Time?
F-DCFPyL PET/CT在原发性前列腺癌诊断、Gleason分级和达米科分类中的性能:一项基于放射组学的研究。
Phenomics. 2023 Jul 25;3(6):576-585. doi: 10.1007/s43657-023-00108-y. eCollection 2023 Dec.
4
Comments on Study of "Performance of 18F-DCFPyL PET/CT in Primary Prostate Cancer Diagnosis, Gleason Grading and D'Amico Classification: A Radiomics-Based Study".关于“18F-DCFPyL PET/CT在原发性前列腺癌诊断、 Gleason分级和达米科分类中的性能:一项基于放射组学的研究”的评论
Phenomics. 2023 Dec 4;3(6):639-641. doi: 10.1007/s43657-023-00143-9. eCollection 2023 Dec.
5
Robustness of apparent diffusion coefficient-based lymph node classification for diagnosis of prostate cancer metastasis.基于表观扩散系数的淋巴结分类对前列腺癌转移诊断的稳健性。
Eur Radiol. 2024 Jul;34(7):4504-4515. doi: 10.1007/s00330-023-10406-8. Epub 2023 Dec 15.
6
Clinical Significance of Radical Prostatectomy in Clinical Lymph Node Metastasis in Prostate Cancer.根治性前列腺切除术在前列腺癌临床淋巴结转移中的临床意义
Ann Surg Oncol. 2023 Nov;30(12):7903-7909. doi: 10.1245/s10434-023-14137-4. Epub 2023 Sep 10.
7
Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations.转移性去势抵抗性前列腺癌患者中前列腺特异性膜抗原靶向诊疗的肿瘤汇效应:个体内评估
Cancers (Basel). 2023 May 3;15(9):2592. doi: 10.3390/cancers15092592.
8
Negative predictive value of PSMA PET scan for lymph node staging in patients undergoing robotic radical prostatectomy and pelvic lymph node dissection.PSMA PET扫描对接受机器人辅助根治性前列腺切除术和盆腔淋巴结清扫术患者进行淋巴结分期的阴性预测值。
Int Urol Nephrol. 2023 Jun;55(6):1453-1457. doi: 10.1007/s11255-023-03595-0. Epub 2023 Apr 22.
9
Evaluation of the role of local therapy in patients with cN1M0 prostate cancer: A population-based study from the SEER database.cN1M0期前列腺癌患者局部治疗作用的评估:一项基于监测、流行病学和最终结果(SEER)数据库的人群研究
Front Oncol. 2022 Dec 5;12:1050317. doi: 10.3389/fonc.2022.1050317. eCollection 2022.
10
New Radionuclides and Technological Advances in SPECT and PET Scanners.SPECT和PET扫描仪中的新型放射性核素与技术进展
Cancers (Basel). 2021 Dec 8;13(24):6183. doi: 10.3390/cancers13246183.
前列腺癌淋巴结复发患者行挽救性淋巴结清扫术:时机是否成熟?
Eur Urol. 2017 May;71(5):693-694. doi: 10.1016/j.eururo.2016.12.001. Epub 2016 Dec 30.
4
The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels.前列腺特异性抗原水平较低的前列腺癌患者再分期中PSMA PET/CT成像的作用。
Nucl Med Commun. 2017 Feb;38(2):149-155. doi: 10.1097/MNM.0000000000000617.
5
F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients.F-18标记的PSMA-1007:前列腺癌患者肿瘤病灶的生物分布、辐射剂量测定及组织病理学验证
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):678-688. doi: 10.1007/s00259-016-3573-4. Epub 2016 Nov 26.
6
Impact of Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(Ga-PSMA PET/CT)对前列腺癌患者且前列腺切除术后前列腺特异性抗原(PSA)持续升高或生化复发患者挽救性放射治疗计划的影响
EJNMMI Res. 2016 Dec;6(1):78. doi: 10.1186/s13550-016-0233-4. Epub 2016 Oct 26.
7
Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer.前列腺特异性膜抗原(PSMA)配体用于前列腺癌的诊断和治疗。
Expert Rev Mol Diagn. 2016 Nov;16(11):1177-1188. doi: 10.1080/14737159.2016.1243057. Epub 2016 Oct 14.
8
Sensitivity, Specificity, and Predictors of Positive Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis.前列腺特异性膜抗原正电子发射断层扫描在晚期前列腺癌中的敏感性、特异性和阳性预测值:系统评价和荟萃分析。
Eur Urol. 2016 Dec;70(6):926-937. doi: 10.1016/j.eururo.2016.06.021. Epub 2016 Jun 28.
9
Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.68镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描对前列腺癌术前淋巴结分期的前瞻性评估
BJU Int. 2017 Feb;119(2):209-215. doi: 10.1111/bju.13540. Epub 2016 Jun 18.
10
Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer.镓-PSMA 正电子发射断层扫描/计算机断层扫描为前列腺癌患者在淋巴结清扫前提供准确的淋巴结区域分期。
Eur Urol. 2016 Oct;70(4):553-557. doi: 10.1016/j.eururo.2015.12.051. Epub 2016 Jan 19.